Morgan Stanley’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $259K | Buy |
|
|||||
|
2025
Q1 | $108K | Sell |
|
|||||
|
2024
Q4 | $184K | Sell |
|
|||||
|
2024
Q3 | $229K | Buy |
|
|||||
|
2024
Q2 | $86.8K | Buy |
|
|||||
|
2024
Q1 | $99.7K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $47.1K | Buy |
|
|||||
|
2023
Q2 | $26.8K | Buy |
|
|||||
|
2023
Q1 | $7.95K | Sell |
|
|||||
|
2022
Q4 | $19K | Sell |
|
|||||
|
2022
Q3 | $18K | Sell |
|
|||||
|
2022
Q2 | $65K | Sell |
|
|||||
|
2022
Q1 | $41K | Sell |
|
|||||
|
2021
Q4 | $470K | Buy |
|
|||||
|
2021
Q3 | $321K | Sell |
|
|||||
|
2021
Q2 | $458K | Buy |
|
|||||
|
2021
Q1 | $302K | Buy |
|
|||||
|
2020
Q4 | $116K | Buy |
|
|||||
|
2020
Q3 | $16K | Sell |
|
|||||
|
2020
Q2 | $103K | Buy |
|
|||||
|
2020
Q1 | $52K | Sell |
|
|||||
|
2019
Q4 | $83K | Sell |
|
|||||
|
2019
Q3 | $258K | Sell |
|
|||||
|
2019
Q2 | $1.78M | Buy |
|
|||||
|
2019
Q1 | $54K | Sell |
|
|||||
|
2018
Q4 | $181K | Sell |
|
|||||
|
2018
Q3 | $273K | Sell |
|
|||||
|
2018
Q2 | $412K | Buy |
|
|||||
|
2018
Q1 | $792K | Buy |
|
|||||
|
2017
Q4 | $44K | Buy |
|
|||||
|
2017
Q3 | $1K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $0 | Sell |
|
|||||
|
2016
Q2 | $21K | Buy |
|
|||||
|
2016
Q1 | $17K | Buy |
|
|||||
|
2015
Q4 | $31K | Sell |
|
|||||
|
2015
Q3 | $84K | Sell |
|
|||||
|
2015
Q2 | $457K | Sell |
|
|||||
|
2015
Q1 | $542K | Buy |
|
|||||
|
2014
Q4 | $455K | Sell |
|
|||||
|
2014
Q3 | $496K | Buy |
|
|||||
|
2014
Q2 | $840K | Buy |
|
|||||
|
2014
Q1 | $546K | Buy |
|
|||||
|
2013
Q4 | $293K | Buy |
|
|||||
|
2013
Q3 | $242K | Sell |
|
|||||
|
2013
Q2 | $498K | Buy |
|